approval
savePRALUENT (ALIROCUMAB) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPRALUENT (ALIROCUMAB) — FDA approvalOct 9, 2025 · 356d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 8, 2024 · 936d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2008d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2008d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 10, 2020 · 2395d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2714d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2714d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalNov 6, 2018 · 2885d ago
comments(0)
5-min edit window · permanent after that